Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

ea0065p130 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Nuclear receptor profiling predicts chemical disruptors as risk factors for developing breast cancer

ea0065p131 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Inflammatory cytokines dysregulate oestrogen metabolism in colorectal cancer

ea0065p132 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Risk stratification of variants of unknown significance (VUS) in monogenic endocrine tumour genes using population-level genetic data and computational analysis

ea0065p133 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Tumour detection and outcomes of surveillance screening in SDHB and SDHD mutation carriers

ea0065p134 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

PLK1 inhibitors as potential new treatment for adrenocortical carcinoma

ea0065p135 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

The impact of gastrointestinal symptoms on quality of life in people with MEN2B

ea0065p136 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Profiling of tissue inflammatory cytokine expression in a pancreatic neuroendocrine tumour mouse model identifies upregulation of the chemokine C-C motif ligand 2 (CCL2)

ea0065p137 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Long term outcomes following parathyroidectomy in patients with multiple endocrine neoplasia type 1: A retrospective cohort study

ea0065p138 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Targeting oestrogen synthesis and action as a novel therapy for colorectal cancer

ea0065p139 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Clinical spectrum of endocrine toxicities of Immune checkpoint therapy: single centre experience

ea0065p140 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

A cyclin dependent kinase inhibitor 1B missense mutation (Pro69Leu) is associated with familial hypomagnesaemia, but not multiple endocrine neoplasia type 4 (MEN4)

ea0065p141 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Predicting hypophysitis in patients treated with immune checkpoint inhibitors: can prolactin be used as a marker of incipient disease?

ea0065p142 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Living with and beyond childhood cancer – endocrine impact up to 40 years on

ea0065p143 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Ipilimumab-induced hypophysitis: a longitudinal analysis in a cohort of patients with metastatic melanoma

ea0065p144 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

The yield and cost of radiological screening in von Hippel–Lindau disease

ea0065p145 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

DI patients vote for a name change to pituitary insipidus to improve safety – a survey

ea0065p146 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Frequency of pathogenic germline variants in hereditary endocrine tumour genes in patients with discordant cancer phenotypes

ea0065p147 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Lobectomy for thyroid cancer and thyroglobulin as a tumor marker for long term follow up: current controversies and clarification

ea0065p148 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

An audit on a teenage and young adult (TYA) neuro-oncology and late effects clinic

ea0065p149 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Prolonged supervised fast for insulinoma – an experience in a District General Hospital Trust

ea0065p150 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Breast cancer in MEN1: coincidence or association?

ea0065p151 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

A post implementation audit of a local Chromogranin A service – a step towards individualised patient care

ea0065p152 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

The expression pattern of miR-16, 21, 145, and 375 in plasma of breast cancer patients at different clinical stages

ea0065p153 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Ipilimumab-induced hypophysitis with normal pituitary function: a series of 3 cases

ea0065p154 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Audit of biochemical screening for multiple endocrine neoplasia type 1 in patients diagnosed with pancreatic neuroendocrine tumours

ea0065p158 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Palliative electrochemotherapy treatment in a patient with advanced thyroid papillary carcinoma with cutaneous metastases

ea0065p159 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Recurrent hyperparathyroidism in a patient with multiple endocrine neoplasia type 1 (MEN1) after total parathyroidectomy with autotransplantation unmasked by depression and vague abdominal pain

ea0065p160 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Irradiation and endocrinopathies: multiple complications in a single patient

ea0065p161 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

A rare case of Small cell lung carcinoma with dual ADH and ACTH secretion

ea0065p162 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Transient adrenal insufficiency in a patient with an insulinoma

ea0065p163 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Impact of diabetes education in patients with newly diagnosed diabetes

ea0065p164 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Case report on Immunotherapy mediated hypocortisolemia

ea0065p165 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer

Society for Endocrinology BES 2019

BiosciAbstracts